- Scheme Category:
- Other Scheme >
- Index Funds
NAV: ₹ ↑ 0.07%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 40 SMA
- 500 SMA
Returns
CAGR returns till date
CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth and its peers as on 13 November, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth | 22.04% | 0.07% | 1.98% | 9.45% | 5.65% | 22.69% | 21.88% | 15.77% | - | - |
| SBI NIFTY INDEX FUND - DIRECT PLAN - GROWTH | -3.07% | -0.61% | 0.47% | 10.71% | 3.11% | -2.1% | 9.91% | 7.77% | 12.23% | 12.64% |
| SBI Nifty Next 50 Index Fund - Direct Plan - Growth | 5.21% | -0.83% | 1.7% | 5.79% | -2.42% | 4.93% | 17.13% | 11.05% | - | - |
| SBI CPSE Bond Plus SDL Sep 2026 50:50 Index Fund - Direct Plan - Growth | 4.4% | 0.01% | 0.1% | 0.46% | 1.4% | 5.95% | 7.22% | - | - | - |
| SBI CRISIL IBX Gilt Index - April 2029 Fund - Direct Plan - Growth | 3.22% | 0.02% | 0.16% | 0.44% | 0% | 4.02% | 7.38% | - | - | - |
| SBI |CRISIL IBX Gilt Index - June 2036 Fund - Direct Plan - Growth | 2.16% | -0.17% | -0.6% | 1% | -1.77% | 2.78% | 7.2% | - | - | - |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | 16.96% | -3.92% | 27.42% | 27.77% | 5.49% |
Discrete returns (monthly)
| Month | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -2.51% | 5.16% | -4.55% | 2.98% | 2.43% | 7.08% | 4.05% | 2.49% | -2.55% | 4.58% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.89% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.11% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.99% | |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.96% | |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.51% | |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 4.52% | |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.45% | |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.38% | |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 4.14% | |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 3.56% | |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.08% | |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.76% | |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.74% | |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.15% | |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.70% | |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.64% | |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.54% | |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.37% | |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 1.33% | |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 1.32% | |
| Aster DM Quality Care Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 1.08% | |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 0.97% | |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 0.73% | |
| GlaxoSmithKline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.72% | |
| Narayana Hrudayalaya ltd. | NH (INE410P01011) | Healthcare Services | 0.71% | |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.48% | |
| ELI LILLY & CO | (US5324571083) | Pharmaceuticals | 6.34% | |
| JOHNSON & JOHNSON | (US4781601046) | Pharmaceuticals | 4.37% | |
| ABBVIE INC | (US00287Y1091) | Biotechnology | 3.10% | |
| MERCK & CO.INC | (US58933Y1055) | Pharmaceuticals | 2.49% | |
| NOVARTIS AG | (US66987V1098) | Pharmaceuticals | 1.90% | |
| AMGEN INC | (US0311621009) | Biotechnology | 1.58% | |
| THERMO FISHER SCIENTIFIC INC | (US8835561023) | Life Sciences Tools & Services | 1.57% | |
| ABBOTT LABORATORIES | (US0028241000) | Health Care Equipment & Supplies | 1.31% | |
| GILEAD SCIENCES INC | (US3755581036) | Biotechnology | 1.24% | |
| Novo Nordisk A/S | (US6701002056) | Pharmaceuticals & Biotechnology | 1.00% | |
| VERTEX PHARMACEUTICALS INC | (US92532F1003) | Biotechnology | 0.95% | |
| DANAHER CORP | (US2358511028) | Health Care Equipment & Supplies | 0.93% | |
| INTUITIVE SURGICAL INC | (US46120E6023) | Health Care Equipment & Supplies | 0.91% | |
| MEDTRONIC PLC | (IE00BTN1Y115) | Health Care Equipment & Supplies | 0.79% | |
| STRYKER CORP | (US8636671013) | Health Care Equipment & Supplies | 0.76% | |
| Regeneron Pharmaceuticals Inc | (US75886F1075) | Pharmaceuticals | 0.57% | |
| BECTON DICKINSON AND CO | (US0758871091) | Health Care Equipment & Supplies | 0.37% | |
| IQVIA HOLDINGS INC | (US46266C1053) | Life Sciences Tools & Services | 0.30% | |
| AGILENT TECHNOLOGIES INC | (US00846U1016) | Life Sciences Tools & Services | 0.30% | |
| WATERS CORP | (US9418481035) | Pharmaceuticals | 0.28% |
Portfolio data is as on date 31 August, 2026
NAV history
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 13 November, 2026 | 26.1562 | 0.07% |
| 12 November, 2026 | 26.1379 | -0.41% |
| 11 November, 2026 | 26.2461 | -0.23% |
| 9 November, 2026 | 26.3076 | 2.57% |
| 6 November, 2026 | 25.6479 | 0.32% |
| 5 November, 2026 | 25.5649 | -0.52% |
| 4 November, 2026 | 25.6994 | 1.56% |
| 3 November, 2026 | 25.3042 | 0.2% |
| 2 November, 2026 | 25.2526 | -0.11% |
| 30 October, 2026 | 25.2802 | 1.28% |
| 29 October, 2026 | 24.9619 | 1.42% |
| 28 October, 2026 | 24.6135 | 0.92% |
| 27 October, 2026 | 24.3885 | 1.23% |
| 26 October, 2026 | 24.0919 | 1.35% |
| 23 October, 2026 | 23.7706 | -0.88% |
| 22 October, 2026 | 23.9821 | 0.51% |
| 21 October, 2026 | 23.861 | 0.33% |
| 19 October, 2026 | 23.7819 | -0.99% |
| 16 October, 2026 | 24.019 | -0.22% |
| 15 October, 2026 | 24.071 | 0.86% |
| 14 October, 2026 | 23.8646 | -0.14% |
| 13 October, 2026 | 23.8969 | -0.74% |
| 12 October, 2026 | 24.0754 | -0.16% |
| 9 October, 2026 | 24.1134 | 1.09% |
| 8 October, 2026 | 23.8533 | -1.78% |
| 7 October, 2026 | 24.2845 | 0.3% |
| 6 October, 2026 | 24.2114 | 0.82% |
| 5 October, 2026 | 24.0146 | -0.55% |
| 1 October, 2026 | 24.1477 | -0.66% |
| 30 September, 2026 | 24.3091 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The latest NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is 26.1562 as on 13 November, 2026.What are YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 22.04% as on 13 November, 2026.What are 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 22.69% as on 13 November, 2026.What are 3 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 3 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 21.88% as on 13 November, 2026.What are 5 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 5 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 15.77% as on 13 November, 2026.